Aquestive Therapeutics Inc (AQST) returns
Aquestive Therapeutics returns over 5 years
$1,000 invested in Aquestive Therapeutics five years ago was worth $756.81 at the close on October 30, 2026, with dividends reinvested: an average return of -5.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -16.0% | — | $840.17 | -0.9% |
| 3 months | +4.6% | — | $1,046 | +2.1% |
| Year to date | -39.8% | — | $602.17 | +11.7% |
| 1 year | -41.6% | — | $584.08 | +12.4% |
| 3 years | +157.6% | +37.1% | $2,576 | +88.5% |
| 5 years | -24.3% | -5.4% | $756.81 | +76.0% |
Aquestive Therapeutics return by calendar year
| Year | AQST | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -39.8% | +11.7% | -51.5% |
| 2025 | +81.5% | +17.7% | +63.7% |
| 2024 | +76.2% | +24.9% | +51.4% |
| 2023 | +123.9% | +26.2% | +97.7% |
| 2022 | -76.8% | -18.2% | -58.6% |
| 2021 | -27.3% | +28.7% | -56.0% |
| 2020 | -8.1% | +18.4% | -26.4% |
| 2019 | -7.6% | +31.2% | -38.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: AQST financials
No forecast, no recommendation. This page describes Aquestive Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.